Cargando…

Review of the Treatment of Restless Legs Syndrome: Focus on Gabapentin Enacarbil

The FDA approved gabapentin enacarbil in 2011 as the first non-dopaminergic agent for the treatment of restless legs syndrome (RLS) symptoms. Although gabapentin enacarbil is a pro-drug of gabapentin, its pharmacokinetics differ. Absorption of gabapentin enacarbil is more predictable, and inter-pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burke, Rachel A., Faulkner, Michele A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619699/ https://www.ncbi.nlm.nih.gov/pubmed/23650473 http://dx.doi.org/10.4137/JCNSD.S9107

Ejemplares similares

Gabapentin Enacarbil: Pharmacotherapy of Restless Legs Syndrome
por: Jones, Ruth, et al.
Publicado: (2010)

Role of gabapentin enacarbil XR in restless legs syndrome
por: Sivam, Sheila, et al.
Publicado: (2012)

Gabapentin enacarbil – clinical efficacy in restless legs syndrome
por: Agarwal, Pinky, et al.
Publicado: (2010)

Gabapentin enacarbil for the treatment of moderate to severe primary restless legs syndrome (Willis-Ekbom disease): 600 or 1,200 mg dose?
por: Kume, Akito
Publicado: (2014)

Gabapentin enacarbil extended release for the treatment of postherpetic neuralgia in adults
por: Thomas, Ben M, et al.
Publicado: (2013)

Effect of prior exposure to dopamine agonists on treatment with gabapentin enacarbil in adults with moderate-to-severe primary restless legs syndrome: pooled analyses from 3 randomized trials
por: Ondo, William G, et al.
Publicado: (2015)

Successful Management of Clozapine-induced Akathisia with Gabapentin Enacarbil: A Case Report
por: Takeshima, Masahiro, et al.
Publicado: (2018)

Restless Legs Syndrome and Leg Motor Restlessness in Parkinson's Disease
por: Suzuki, Keisuke, et al.
Publicado: (2015)

Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study
por: Takeshima, Masahiro, et al.
Publicado: (2018)

A Comment on “Successful Management of Clozapine-induced Akathisia with Gabapentin Enacarbil: A Case Report”
por: Naguy, Ahmed
Publicado: (2019)

Ropinirole for the treatment of restless legs syndrome
por: Kushida, Clete A
Publicado: (2006)

Gabapentin Enacarbil Extended‐Release Versus Placebo: A Likely Responder Reanalysis of a Randomized Clinical Trial
por: Laska, Eugene M., et al.
Publicado: (2020)

Comparison of the Efficacy of Gabapentin Versus Levodopa-C for the Treatment of Restless Legs Syndrome in End-Stage Renal Disease on Hemodialysis Patients
por: Ali, Muhammad, et al.
Publicado: (2020)

The Neurobiology and Treatment of Restless Legs Syndrome
por: Jones, Ruth, et al.
Publicado: (2013)

Pharmacologic Treatment of Restless Legs Syndrome
por: Lv, Qing, et al.
Publicado: (2021)

Restless legs syndrome: diagnosis and review of management options
por: Byrne, Ruth, et al.
Publicado: (2006)

Treatment of Leg Veins for Restless Leg Syndrome: A Retrospective Review
por: Sundaresan, Swaminathan, et al.
Publicado: (2019)

Migraine and restless legs syndrome: is there an association?
por: Cannon, Paul R., et al.
Publicado: (2011)

Restless leg syndrome: is it a real problem?
por: Cotter, Paul E, et al.
Publicado: (2006)

Effects of restless legs syndrome (RLS) on sleep
por: Bogan, Richard K
Publicado: (2006)

The biopsychosocial effects of restless legs syndrome (RLS)
por: Becker, Philip M
Publicado: (2006)

Interindividual Variability in the Bioavailability of Gabapentin Enacarbil Extended Release in Healthy Adults: An Analysis of Data From 6 Phase I Studies
por: Lal, Ritu, et al.
Publicado: (2022)

Update on the management of restless legs syndrome: existing and emerging treatment options
por: Facheris, Maurizio F, et al.
Publicado: (2010)

The Effect of Selenium Administration on Restless Leg Syndrome Treatment
por: Rahimdel, A G, et al.
Publicado: (2012)

Restless Leg Syndrome: A Neglected Diagnosis
por: Einollahi, Behzad, et al.
Publicado: (2014)

Alterations of Functional Connectivity in Patients With Restless Legs Syndrome
por: Park, Kang Min, et al.
Publicado: (2022)

Restless Chest Syndrome: A Rare Variant of Restless Legs Syndrome
por: Ishizuka, Kosuke, et al.
Publicado: (2022)

Restless Legs Syndrome as a Comorbidity in Rheumatoid Arthritis
por: Gjevre, John A., et al.
Publicado: (2013)

Differential Diagnosis and Treatment of Restless Legs Syndrome: A Literature Review
por: Kwatra, Vishal, et al.
Publicado: (2018)

Restless legs syndrome: differential diagnosis and management with pramipexole
por: Brindani, Francesca, et al.
Publicado: (2009)

Restless legs syndrome: An overview of pathophysiology, comorbidities and therapeutic approaches (Review)
por: Vlasie, Andrei, et al.
Publicado: (2022)

Possible etiologies of restless legs syndrome in pregnancy: a narrative review
por: Mendes, Ana, et al.
Publicado: (2022)

Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review
por: Safarpour, Yasaman, et al.
Publicado: (2023)

Vitamin D and Restless Legs Syndrome: A Review of Current Literature
por: Cederberg, Katie L. J., et al.
Publicado: (2023)

Restless Legs Syndrome: The underrecognised condition
por: Benamer, Hani
Publicado: (2006)

Migraine with aura and restless legs syndrome
por: Larner, Andrew J.
Publicado: (2007)

Peripheral Dopamine in Restless Legs Syndrome
por: Mitchell, Ulrike H., et al.
Publicado: (2018)

Unraveling the Mysteries of Restless Leg Syndrome
por: Memon, Mohammad D, et al.
Publicado: (2020)

Restless legs syndrome: causes and consequences
por: Massey, T. H., et al.
Publicado: (2020)

Circadian rhythm in restless legs syndrome
por: Tang, Mingyang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1pui9ji0qm7fka2idmqhjqbpad